Custom cancer treatment strategy tested in major new study
NCT ID NCT07045168
Summary
This study aims to test a personalized treatment approach for people newly diagnosed with multiple myeloma, a blood cancer. Researchers will use a scoring system to determine each patient's risk level and assign different treatment combinations accordingly. The study will track 200 participants to see if this personalized approach helps keep the cancer under control longer and improves survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.